Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or Autoinjector

NCT02606903 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim